What You Should Know:
– The Investment: Lantern has secured a $30 million growth investment led by Morgan Health (JPMorganChase) and Echo Health Ventures to accelerate expansion across employers and health plans.
– The Core Problem: Specialty care remains the largest cost driver in U.S. healthcare, with rising prices, fragmented navigation, and poor patient experiences burdening both employers and members.
– Commercial Traction: Lantern serves over 12 million members, partners with 1,000+ employers and unions, and recently added major clients and partnerships while expanding capabilities through acquisitions and AI-enabled navigation.
Lantern Raises $30M to Scale Its Network-of-Excellence Model for Specialty Care
Lantern, a specialty care platform serving over 12 million individuals across the U.S., has announced a $30 million growth investment from Morgan Health and Echo Health Ventures. The funding is aimed at expanding its reach across public and private employers as well as health plans, building on its demonstrated ability to reduce specialty care costs while improving clinical outcomes and patient experience.
The company’s model centers on a “Network of Excellence,” which moves beyond traditional centers of excellence by directly contracting with high-performing providers nationwide. This approach increases accessibility while maintaining high clinical standards, targeting key cost drivers such as surgery, cancer care, and infusions. By optimizing site-of-care decisions and leveraging value-based contracts, Lantern reports savings of up to $20 per employee per month, alongside reductions in complications and downstream healthcare utilization.
Lantern’s platform integrates detailed clinical evaluation—using hundreds of appropriateness and outcomes metrics—with negotiated pricing that can be significantly lower than standard commercial rates. These efficiencies have translated into measurable impact, including billions in cumulative savings and improved patient-reported outcomes, supported by a concierge-style navigation experience that enhances member engagement.
The investment follows a period of rapid growth, with Lantern onboarding over 100 new clients in 2025 alone and expanding its footprint through high-profile employer partnerships and public sector contracts. Strategic developments, including the integration of Specialist Management Solutions and partnerships with organizations like AccessHope and Quantum Health, have further strengthened its capabilities in early patient identification, cancer navigation, and coordinated specialty care delivery.
“We leverage robust cost analytics, clinical data on outcomes, appropriateness measures, and dynamic value-based contracting to get people to great care, close to home,” said John Zutter, CEO of Lantern.
